Dataset Information


Quantitative acylcarnitine determination by UHPLC-MS/MS--Going beyond tandem MS acylcarnitine "profiles".

ABSTRACT: Tandem MS "profiling" of acylcarnitines and amino acids was conceived as a first-tier screening method, and its application to expanded newborn screening has been enormously successful. However, unlike amino acid screening (which uses amino acid analysis as its second-tier validation of screening results), acylcarnitine "profiling" also assumed the role of second-tier validation, due to the lack of a generally accepted second-tier acylcarnitine determination method. In this report, we present results from the application of our validated UHPLC-MS/MS second-tier method for the quantification of total carnitine, free carnitine, butyrobetaine, and acylcarnitines to patient samples with known diagnoses: malonic acidemia, short-chain acyl-CoA dehydrogenase deficiency (SCADD) or isobutyryl-CoA dehydrogenase deficiency (IBD), 3-methyl-crotonyl carboxylase deficiency (3-MCC) or ß-ketothiolase deficiency (BKT), and methylmalonic acidemia (MMA). We demonstrate the assay's ability to separate constitutional isomers and diastereomeric acylcarnitines and generate values with a high level of accuracy and precision. These capabilities are unavailable when using tandem MS "profiles". We also show examples of research interest, where separation of acylcarnitine species and accurate and precise acylcarnitine quantification is necessary.


PROVIDER: S-EPMC5009370 | BioStudies | 2015-01-01

REPOSITORIES: biostudies

Similar Datasets

2019-01-01 | S-EPMC6695155 | BioStudies
2015-01-01 | S-EPMC5577792 | BioStudies
1000-01-01 | S-EPMC4583086 | BioStudies
2018-01-01 | S-EPMC6057484 | BioStudies
2017-01-01 | S-EPMC5701125 | BioStudies
2001-01-01 | S-EPMC1226127 | BioStudies
2019-01-01 | S-EPMC6339774 | BioStudies
2019-01-01 | S-EPMC6383405 | BioStudies
2013-01-01 | S-EPMC3755585 | BioStudies
| S-EPMC7277087 | BioStudies